| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000039758 |
| Receipt No. | R000045347 |
| Scientific Title | Study on antibacterial effect and smell of armpit reduction effect of erythritol application |
| Date of disclosure of the study information | 2020/03/11 |
| Last modified on | 2020/09/08 (Ver. 3) |
| Basic information | ||
| Public title | Study on antibacterial effect and smell of armpit reduction effect of erythritol application | |
| Acronym | Deodorant test of erythritol application | |
| Scientific Title | Study on antibacterial effect and smell of armpit reduction effect of erythritol application | |
| Scientific Title:Acronym | Deodorant test of erythritol application | |
| Region |
|
|
| Condition | ||
| Condition | Healthy Adults | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | Evaluate antibacterial effect and smell of armpit reduction effect after 24 hours by applying the test product |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Intensity of smell of armpit by sensory evaluation after 24 hours the test product application |
| Key secondary outcomes | Type of smell of armpit by sensory evaluation after 24 hours the test product application
Smell of armpit related bacteria count Physical examination (height, weight, BMI) |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Single blind -investigator(s) and assessor(s) are blinded |
| Control | Placebo |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Prevention | |
| Type of intervention |
|
|
| Interventions/Control_1 | After washing the body, apply erythritol-containing solution to the same subject's right armpit. | |
| Interventions/Control_2 | After washing the body, apply an erythritol-free solution (placebo) to the same subject's left armpit. | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1. Persons who received a sufficient explanation of the purpose and contents of the exam, have the capacity to consent, applied with free will with sufficient understanding, and agreed to participate with a written document
2. Healthy Japanese who are 16 years old or more and under 60 years old 3. Persons who are concerned about smell of armpit 4. Select 20 patients taking into account the intensity of smell of armpit, gender and age at the screening |
|||
| Key exclusion criteria | 1. Persons who have chronic illness, receiving medication, have a serious disease history
2. Persons who have a smoking habit 3. Persons who have a hospital visit for treatment of smell of armpit 4. Persons who regularly drink a large amount (more than 3 Japanese sake per day) 5. BMI less than 18.5, 25 or more 6. Persons who are on a diet 7. Persons who are pregnant, planning or hoping to be pregnant during the study period, breastfeeding 8. Persons with menopausal symptoms (subjective symptoms such as hot flashes), immediately after menopause 9. Workers on the night shift 10. Persons who regularly use medicines, specified insurance foods, and health foods that may affect smell of armpit 11. Persons who have participated in other tests within the first month before the start of the test, or those who intend to participate in another exam after consenting to this exam 12. Persons who are judged as inappropriate for subjects by the principal investigator 13. Persons who have remarkably different intensity of smell of armpit between left and right armpit at the screening |
|||
| Target sample size | 20 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Healthcare Systems Co., Ltd. | ||||||
| Division name | Research and Development Department | ||||||
| Zip code | 105-0004 | ||||||
| Address | Nisshin Tatemono Shinbashi Bld. 7F, 4-6-15 Shinbashi, Minato-ku, Tokyo, JAPAN | ||||||
| TEL | 03-6809-2722 | ||||||
| masudat@hc-sys.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Healthcare Systems Co., Ltd. | ||||||
| Division name | Research and Development Department | ||||||
| Zip code | 105-0004 | ||||||
| Address | Nisshin Tatemono Shinbashi Bld. 7F, 4-6-15 Shinbashi, Minato-ku, Tokyo, JAPAN | ||||||
| TEL | 03-6809-2722 | ||||||
| Homepage URL | |||||||
| masudat@hc-sys.jp | |||||||
| Sponsor | |
| Institute | Healthcare Systems Co., Ltd. |
| Institute | |
| Department | |
| Funding Source | |
| Organization | B Food Science Co., Ltd. and others |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | The Ethics Committee of Healthcare Systems Co., Ltd. |
| Address | Nisshin Tatemono Shinbashi Bld. 7F, 4-6-15 Shinbashi, Minato-ku, Tokyo, JAPAN |
| Tel | 03-6809-2722 |
| kakehashi@hc-sys.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | 18 |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045347 |